Patent · US Active

Antiviral treatment

US11273163B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

CEBINA GMBH · AT

Inventors

Eszter Nagy · Wien, AT
Gabor Nagy · Redmond, US
Valeria SZIJARTO · Wien, AT
Robert Konrat · Wien, AT

Key dates

Filing date	May 28, 2021
Grant date	Mar 15, 2022
Priority date	—
Expiry date	May 28, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating a subject in need of anti-Coronavirus treatment comprising prophylactic or therapeutic treatment, with an antiviral effective amount of an Azelastine compound, wherein the antiviral effective amount is 0.1-500 μg per dose; use of an Azelastine compound as an antiviral substance in a medicinal product for treating a biological surface to prevent from Coronavirus infection and/or Coronavirus spread, and use of an Azelastine compound as viral disinfectant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.